Overview

An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to document the clinical effects of bupropion and citalopram in a single subject with Friedreich Ataxia.
Phase:
Phase 4
Details
Lead Sponsor:
University of Colorado, Denver
Treatments:
Bupropion
Citalopram
Dexetimide